BMPR2 and pulmonary arterial hypertension: Importantly, leniolisib dose-dependently increased apoptosis as measured by AV/PI staining (Figure 3D) and enhanced caspase 3/7 activity in both the BMPR2 and CAV1 in vitro LOF models of PAH (Supplementary Figure S1).